[HER-2/neu oncogene as prognostic factor in breast carcinoma].
Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano.
M I
MI
Colnaghi
D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D001943:Breast Neoplasms / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis*; D018719:Erb-b2 Receptor Tyrosine Kinases; D012189:Retrospective Studies
D014408:Biomarkers, Tumor; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases
L'oncogene HER-2/neu come fattore prognostico nel carcinoma mammario.